New data shows more number of women are attending breast screening program

NewsGuard 100/100 Score

The number of women attending breast screening has risen, with nearly two million accepting invitations from the NHS Breast Screening Programme in 2007/08, new figures show.

The programme's 2009 annual review shows that 1,994,651 women aged 50 to 70 attended screening in 2007/08, up by 93,418 on the previous year.

Over 73 per cent of the 2.5 million women who received an invitation attended their appointment.

The total number of invitations for screening has also increased - by just over 100,000 women - thanks in part to the fact that units in Bolton, King's College London, Coventry, Manchester and Guildford have started to include women from a wider age group in their screening programmes.

These units are piloting an extension of the screening age ahead of a nationwide roll-out, which will ultimately see all women between the ages of 47 and 73 years receiving invitations for screening.

The increase in screening has been accompanied by a rise in the number of cancers detected.

A total of 16,449 cancers were detected through screening in 2007/08, compared with 14,753 in 2006/07.

Professor Julietta Patnick, director of the NHS Cancer Screening Programmes, commented: "It's encouraging to see the growing number of women being screened for breast cancer. More cancers are being diagnosed by the programme and this means we are helping more women than ever before through early detection and diagnosis.

"Over the past year we have been working hard to implement the age extension to include women between 47 and 73 years old. The extension will guarantee all women will be screened at least once before the age of 50," she added.

Ed Yong, Cancer Research UK's head of health information, said: "We're pleased that more women have made the choice to attend screening this year. The screening programme saves around 1,400 lives each year and even more could be saved if attendance was higher." 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis